Arsani William

Dr. William serves as Managing Partner and Chief Investment Officer of Logos Capital, a global life science investment fund focused on private/public therapeutic innovation. Prior to founding Logos, Dr. William was an investment professional at Farallon Capital Management, where he helped grow the development of Farallon’s biopharma portfolio. Dr. William holds an MD from Harvard Medical School, where he was a Gerald S. Foster Scholar, an MBA from Stanford’s Graduate School of Business, and a BS with Honors in Biology from Stanford University. Dr. William currently serves on the board of Design Therapeutics (NASDAQ: DSGN) and is a board observer on Odyssey Therapeutics.